LC-MS-based metabolomics: An update

Archives of Toxicology

Volumn 88, Issue 8, 2014, Pages 1491-1502

  Fang, Zhong Ze ^a   Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Metabolomics; Pathogenesis; Toxicology; Xenobiotic metabolism

Indexed keywords

FARNESOID X RECEPTOR; GEMFIBROZIL; ISONIAZID; NOSCAPINE; RIFAMPICIN; STABLE ISOTOPE; TRACER; TRICHLOROETHYLENE; DRUG; XENOBIOTIC AGENT;

ALCOHOL LIVER DISEASE; CHEMICAL ANALYSIS; DRUG DETERMINATION; GENETICALLY ENGINEERED MOUSE STRAIN; HUMAN; INFLAMMATORY BOWEL DISEASE; LIQUID CHROMATOGRAPHY; LIVER TOXICITY; MASS SPECTROMETRY; MEDICAL TECHNOLOGY; METABOLISM; METABOLITE; METABOLOMICS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; XENOBIOTIC METABOLISM; ANIMAL; BIOTRANSFORMATION; CHEMISTRY; DEVICES; DISEASE; PROCEDURES;

MUS;

ANIMALS; BIOTRANSFORMATION; CHROMATOGRAPHY, LIQUID; DISEASE; HUMANS; MASS SPECTROMETRY; METABOLOMICS; PHARMACEUTICAL PREPARATIONS; XENOBIOTICS;

EID: 84904961381     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-014-1234-6     Document Type: Review

References (77)

1. Aneja R, Katyal A, Chandra R (2004) Modulatory influence of noscapine on the ethanol-altered hepatic biotransformation system enzymes, glutathione content and lipid peroxidation in vivo in rats. Eur J Drug Metab Pharmacokinet 29:157-162 (Pubitemid 39447013)
2. Bakke B, Stewart PA, Waters MA (2007) Uses of and exposure to trichloroethylene in US industry: a systematic literature review. J Occup Environ Hyg 4:375-390
3. Bujak R, Garcia-Alvarez A, Ruperez FJ et al (2014) Metabolomics reveals metabolite changes in acute pulmonary embolism. J Proteome Res. doi:10.1021/pr400872j
4. Castro-Perez JM, Roddy TP, Shah V et al (2011) Attenuation of Slc27a5 gene expression followed by LC-MS measurement of bile acid reconjugation using metabolomics and a stable isotope tracer strategy. J Proteome Res 10:4683-4691
5. Chen C, Gonzalez FJ, Idle JR (2007) LC-MS-based metabolomics in drug metabolism. Drug Metab Rev 39(2-3):581-597 (Pubitemid 47355739)
6. Chen C, Krausz KW, Idle JR, Gonzalez FJ (2008a) Identification of novel toxicity-associated metabolites by metabolomics and mass isotopomer analysis of acetaminophen metabolism in wild-type and Cyp2e1-null mice. J Biol Chem 283:4543-4559
7. Chen C, Shah YM, Morimura K et al (2008b) Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell Metab 7:135-147 (Pubitemid 351168558)
8. Chen M, Zhou K, Chen X et al (2014) Metabolomic analysis reveals metabolic changes caused by bisphenol A in rats. Toxicol Sci. doi:10.1093/toxsci/kfu016
9. Cheng J, Shah YM, Ma XC et al (2010) Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X Receptor activation. J Pharmacol Exp Ther 335:32-41
10. Cheng J, Krausz KW, Tanaka N, Gonzalez FJ (2012) Chronic exposure to rifaximin causes hepatic steatosis in pregnane X receptor-humanized mice. Toxicol Sci 129:456-468
11. Cheng J, Krausz KW, Li F, Ma XC, Gonzalez FJ (2013) CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid. Toxicol Appl Pharm 266:245-253
12. Cheng J, Fang ZZ, Kim JH, Krausz KW, Tanaka N, Chiang JY, Gonzalez FJ (2014) Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in vitamin D receptor intestine-deficient mice. J Lipid Res 55:455-465
13. Dumas ME, Kinross J, Nicholson JK (2014) Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease. Gastroenterology 146:46-62
14. Duportet X, Aggio RBM, Carneiro S, Villas-Boas SG (2012) The biological interpretation of metabolomic data can be misled by the extraction method used. Metabolomics 8:410-421
15. Espina R, Yu LN, Wang JY et al (2009) Nuclear magnetic resonance spectroscopy as a quantitative tool to determine the concentrations of biologically produced metabolites: implications in metabolites in safety testing. Chem Res Toxicol 22:299-310
16. Evans CR, Karnovsky A, Kovach MA, Standiford TJ, Burant CF, Stringer KA (2013) Untargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health. J Proteome Res. doi:10.1021/pr4007624
17. Fang ZZ, Zhang YY, Ge GB, Huo H, Liang SC, Yang L (2010) Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction. Br J Clin Pharmacol 69:193-199
18. Fang ZZ, Krausz KW, Li F, Cheng J, Tanaka N, Gonzalez FJ (2012) Metabolic map and bioactivation of the anti-tumour drug noscapine. Br J Pharmacol 167:1271-1286
19. Fang ZZ, Krausz KW, Tanaka N et al (2013) Metabolomics reveals trichloroacetate as a major contributor to trichloroethylene-induced metabolic alterations in mouse urine and serum. Arch Toxicol 87:1975-1987
20. Fang ZZ, Krausz KW, Nagaoka K et al (2014) In vivo application of the pure aryl hydrocarbon receptor antagonist GNF-351 is limited to the gastrointestinal track. Br J Pharmacol 171:1735-1746
21. Go YM, Roede JR, Orr M, Liang Y, Jones DP (2014) Integrated redox proteomics and metabolomics of mitochondria to identify mechanisms of Cd toxicity. Toxicol Sci 171:1735-1746
22. Gonzalez-Dominguez R, Garcia-Barrera T, Gomez-Ariza JL (2014) Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease. J Proteomics. doi:10.1016/j.jprot.2014.01.014
23. Hong EJ, Levasseur MP, Dufour CR, Perry MC, Giguere V (2013) Loss of estrogen-related receptor a promotes hepatocarcinogenesis development via metabolic and inflammatory disturbances. Proc Natl Acad Sci USA 110:17975-17980
24. Jansen RS, Kucukosmanoglu A, de Haas M et al (2013) ABC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release. Proc Natl Acad Sci USA 110:20206-20211
25. Jiang LM, Huang J, Wang YL, Tang HR (2012) Metabonomic analysis reveals the Cl4-Induced systems alterations for multiple rat organs. J Proteome Res 11:3848-3859
26. Johnson CH, Gonzalez FJ (2012) Challenges and opportunities of metabolomics. J Cell Phys 227:2975-2981
27. Johnson CH, Patterson AD, Idle JR, Gonzalez FJ (2012a) Xenobiotic metabolomics: major impact on the metabolome. Annu Rev Pharmacol 52:37-56
28. Johnson CH, Slanar O, Krausz KW et al (2012b) Novel metabolites and roles for alpha-tocopherol in humans and mice discovered by mass spectrometry-based metabolomics. Am J Clin Nutr 96:818-830
29. Kim JH, Yamaori S, Tanabe T et al (2013) Implication of intestinal VDR deficiency in inflammatory bowel disease. Bba-Gen Subj 1830:2118-2128
30. Lane AN, Fan TWM, Bousamra M, Higashi RM, Yan J, Miller DM (2011) Stable isotope-resolved metabolomics (SIRM) in cancer research with clinical application to non-small cell lung cancer. OMICS 15:173-182
31. Leichtle AB, Nuoffer JM, Ceglarek U et al (2012) Serum amino acid profiles and their alterations in colorectal cancer. Metabolomics 8:643-653
32. Li F, Miao Y, Zhang LR, Neuenswander SA, Douglas JT, Ma XC (2011) Metabolomic analysis reveals novel isoniazid metabolites and hydrazones in human urine. Drug Metab Pharmacok 26:569-576
33. Li F, Patterson AD, Krausz KW et al (2012) Metabolomics reveals the metabolic map of procainamide in humans and mice. Biochem Pharmacol 83:1435-1444
34. Li F, Jiang CT, Krausz KW et al (2013a) Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat Commun 4:2384
35. Li F, Lu J, Cheng J et al (2013b) Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy. Nat Med 19:418-420
36. Li F, Pang XY, Krausz KW et al (2013c) Stable isotope- and mass spectrometry-based metabolomics as tools in drug metabolism: a study expanding tempol pharmacology. J Proteome Res 12:1369-1376
37. Li F, Patterson AD, Krausz KW et al (2013d) Metabolomics reveals that tumor xenografts induce liver dysfunction. Mol Cell Proteomics 12:2126-2135
38. Li JS, Wang S, Wang MQ, Shi WX, Du XY, Sun CH (2013e) The toxicity of 3-chloropropane-1,2-dipalmitate in Wistar rats and a metabonomics analysis of rat urine by ultra-performance liquid chromatography-mass spectrometry. Chem-Biol Interact 206:337-345
39. Li F, Lu J, Ma XC (2014a) CPY3A4-mediated α-hydroxyaldehyde formation in saquinavir metabolism. Drug Metab Dispos 42:213-220
40. Li M, Li H, Jiang P, Liu X, Xu D, Wang F (2014b) Investigating the pathological processes of rhegmatogenous retinal detachment and proliferative vitreoretinopathy with metabolomics analysis. Mol BioSyst. doi:10.1039/ c3mb70386j
41. Liu A, Krausz KW, Fang ZZ, Brocker C, Qu A, Gonzalez FJ (2014) Gemfibrozil disrupts lysophosphatidylcholine and bile acid homeostasis via PPARα and its relevance to hepatotoxicity. Arch Toxicol. doi:10.1007/s00204-013-1188-0
42. Lu XY, Hu B, Shao L et al (2013) Integrated analysis of transcriptomics and metabonomics profiles in aflatoxin B1-induced hepatotoxicity in rat. Food Chem Toxicol 55:444-455
43. Mahmoudian M, Rahimi-Moghaddam P (2009) The anti-cancer activity of noscapine: a review. Recent Pat Anti-Cancer 4:92-97
44. Manna SK, Patterson AD, Yang QA et al (2010) Identification of non-invasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse. J Proteome Res 9:4176-4188
45. Manna SK, Tanaka N, Krausz KW et al (2014) Biomarkers of coordinate metabolic reprogramming in colorectal tumors in mice and humans. Gastroenterology. doi:10.1053/j.gastro.2014.01.017
46. Matsubara T, Tanaka N, Krausz KW et al (2012) Metabolomics identifies an inflammatory cascade involved in dioxin- and diet-induced steatohepatitis. Cell Metab 16(5):634-644
47. McDunn JE, Li Z, Adam KP et al (2013) Metabolomic signatures of aggressive prostate cancer. Prostate 73(14):1547-1560
48. Menezes LF, Zhou F, Patterson AD et al (2012) Network analysis of a Pkd1-mouse model of autosomal dominant polycystic kidney disease identifies HNF4α as a disease Modifier. PLoS Genet 8:e1003053
49. Mutlib AE (2008) Application of stable isotope-labeled compounds in metabolism and in metabolism-mediated toxicity studies. Chem Res Toxicol 21:1672-1689
50. Patterson AD, Gonzalez FJ, Idle JR (2010) Xenobiotic metabolism: a view through the metabolometer. Chem Res Toxicol 23: 851-860
51. Patterson AD, Bonzo JA, Li F et al (2011a) Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus. J Biol Chem 286(22):19511-19522
52. Patterson AD, Maurhofer O, Beyoglu D et al (2011b) Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer Res 71:6590-6600
53. Patterson AD, Shah YM, Matsubara T, Krausz KW, Gonzalez FJ (2012) Peroxisome proliferator-activated receptor α induction of uncoupling protein 2 protects against acetaminophen-induced liver toxicity. Hepatology 56:281-290
54. Patterson AD, Carlson BA, Li F et al (2013) Disruption of thioredoxin reductase 1 protects Mice from acute acetaminophen-induced hepatotoxicity through enhanced NRF2 activity. Chem Res Toxicol 26:1088-1096
55. Plumb RS, Stumpf CL, Granger JH, Castro-Perez J, Haselden JN, Dear GJ (2003) Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids. Rapid Commun Mass Spectrom 17:2632-2638 (Pubitemid 37498776)
56. Qiu YP, Cai GX, Su MM et al (2010) Urinary metabonomic study on colorectal cancer. J Proteome Res 9:1627-1634
57. Rizza S, Copetti M, Rossi C et al (2014) Metabolomics signature improves the prediction of cardiovascular events in elderly subjects. Atherosclerosis 232:260-264
58. Robertson DG (2005) Metabonomics in toxicology: a review. Toxicol Sci 85:809-822
59. Rosenfeldt MT, O'Prey J, Morton JP et al (2013) p53 status determines the role of autophagy in pancreatic tumour development. Nature 504:296-300
60. Schreiber S, Hampe J (2000) Genomics and inflammatory bowel disease. Curr Opin Gastroenterol 16:297-305 (Pubitemid 32260398)
61. Schuler M, Muehlbauer P, Guzzie P, Eastmond DA (1999) Noscapine hydrochloride disrupts the mitotic spindle in mammalian cells and induces aneuploidy as well as polyploidy in cultured human lymphocytes. Mutagenesis 14:51-56 (Pubitemid 29048240)
62. Shen J, Yan L, Liu S, Ambrosone CB, Zhao H (2013) Plasma metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypes. Transl Oncol 6:757-765
63. Shi XL, Yao D, Chen C (2012) Identification of N-acetyltaurine as a novel metabolite of ethanol through metabolomics-guided biochemical analysis. J Biol Chem 287:6336-6349
64. Smith KJ, Murray IA, Tanos R et al (2011) Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism. J Pharmacol Exp Ther 338:318-327
65. Suh JH, Kanathezhath B, Shenvi S et al (2014) Thiol/redox metabolomic profiling implicates GSH dysregulation in early experimental graft versus host disease. PLoS ONE 9(2):e88868
66. Tanaka N, Matsubara T, Krausz KW, Patterson AD, Gonzalez FJ (2012) Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Hepatology 56:118-129
67. Tianjiao L, Shuai W, Xiansheng M et al (2014) Metabolomics coupled with multivariate data and pathway analysis on potential biomarkers in gastric ulcer and intervention effects of Corydalis yanhusuo Alkaloid. PLoS ONE 9:e82499
68. Tsunoda N, Yoshimura H (1981) Metabolic-fate of noscapine 3 further-studies on identification and determination of the metabolites. Xenobiotica 11:23-32 (Pubitemid 12249864)
69. Walker GS, Ryder TF, Sharma R, Smith EB, Freund A (2011) Validation of isolated metabolites from drug metabolism studies as analytical standards by quantitative NMR. Drug Metab Dispos 39:433-440
70. Wang TJ, Ngo D, Psychogios N et al (2013) 2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Invest 123:4309-4317
71. Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427-434 (Pubitemid 47123518)
72. Yao D, Shi XL, Wang L, Gosnell BA, Chen C (2013) Characterization of differential cocaine metabolism in mouse and rat through metabolomics-guided metabolite profiling. Drug Metab Dispos 41:79-88
73. Yin PY, Peter A, Franken H et al (2013) Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. Clin Chem 59:833-845
74. Zhang YY, Li F, Patterson AD et al (2012) Abcb11 deficiency induces cholestasis coupled to impaired β-fatty acid oxidation in mice. J Biol Chem 287:24784-24794
75. Zhang N, Seguin RP, Kunze KL, Zhang YY, Jeong H (2013a) Characterization of inhibition kinetics of (S)-warfarin hydroxylation by noscapine: implications in warfarin therapy. Drug Metab Dispos 41:2114-2123
76. Zhang Z, Lu C, Liu X et al (2013b) Global and targeted metabolomics reveal that bupleurotoxin, a toxic type of polyacetylene, induces cerebral lesion by inhibiting GABA receptor in mice. J Proteome Res. doi:10.1021/ pr400968c
77. Zhao X, Xu F, Qi B et al (2014) Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography-mass spectrometry. J Proteome Res 13:1101-1111